Literature DB >> 32263078

Effect of the protein corona on the colloidal stability and reactivity of LDH-based nanocarriers.

Cecilia Vasti1, Dariana Aristizabal Bedoya, Ricardo Rojas, Carla E Giacomelli.   

Abstract

The physicochemical properties of drug nanocarriers such as layered double hydroxide nanoparticles (LDH-NPs) determine their circulation times in biological media and their interaction with the targeted cells. Nevertheless, the components of the biological fluid, and particularly the formation of a protein corona, change the properties of as-prepared nanocarriers. Here, we discuss the effect of the protein corona formation on the colloidal stability and reactivity of LDH-NPs intercalated with chloride (LDH-Cl), carbonate (LDH-CO3) or dodecylsulfate (LDH-DS). These solids present model physicochemical properties (hydrophillic character, surface charge, and exchange capacity) that can be obtained depending on the interaction of drugs with LDH layers. The colloidal stability of LDH-NPs was determined in simulated biological fluids at high ionic strength and/or the presence of albumin (the main protein of human blood plasma), whereas the reactivity was evaluated by dissolution kinetics in acidic media, compatible with the environment of cell internalized nanocarriers. The protein corona increased the colloidal stability of the nanocarriers by steric hindrance at high ionic strength, reverted the positive zeta potential of as-prepared LDH-NPs and protected them from dissolution at low pHs. The properties of the anionic cargo of LDH-NPs strongly affected the protein corona and hence the fate of NPs in biological fluids. Drug nanocarriers with interfacial properties similar to those of LDH-Cl and LDH-CO3 seem to be more promising than LDH-DS in forming a protein corona. Then, LDH-Cl and LDH-CO3 would enable long circulation times due to their size, colloidal stability and low protein damage. Our results indicate that LDH-NPs preserve and even improve their properties as drug nanocarriers after interacting with the biological media, particularly their ability to reach the site of therapeutic action from the injection place.

Entities:  

Year:  2016        PMID: 32263078     DOI: 10.1039/c5tb02698a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  6 in total

1.  Effects of Surface Protein Adsorption on the Distribution and Retention of Intratumorally Administered Gold Nanoparticles.

Authors:  Rossana Terracciano; Aobo Zhang; E Brian Butler; Danilo Demarchi; Jason H Hafner; Alessandro Grattoni; Carly S Filgueira
Journal:  Pharmaceutics       Date:  2021-02-05       Impact factor: 6.321

2.  Finely crafted quasi-core-shell gadolinium/layered double hydroxide hybrids for switching on/off bimodal CT/MRI contrasting nanodiagnostic platforms.

Authors:  Sang-Yong Jung; Gyeong-Hyeon Gwak; Jin Kuen Park; Jae-Min Oh
Journal:  RSC Adv       Date:  2020-02-05       Impact factor: 4.036

Review 3.  Multivalent ACE2 engineering-A promising pathway for advanced coronavirus nanomedicine development.

Authors:  Eugene M Obeng; Isaac Fianu; Michael K Danquah
Journal:  Nano Today       Date:  2022-08-04       Impact factor: 18.962

4.  Photochemical Consideration in the Interactions between Blood Proteins and Layered Inorganic Materials.

Authors:  Tetsuo Yamaguchi; Hyoung-Mi Kim; Jae-Min Oh
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

5.  ZnAl nano layered double hydroxides for dual functional CRISPR/Cas9 delivery and enhanced green fluorescence protein biosensor.

Authors:  Navid Rabiee; Mojtaba Bagherzadeh; Amir Mohammad Ghadiri; Ghazal Salehi; Yousef Fatahi; Rassoul Dinarvand
Journal:  Sci Rep       Date:  2020-11-26       Impact factor: 4.379

6.  Nanocomposite-based dual enzyme system for broad-spectrum scavenging of reactive oxygen species.

Authors:  Marko Pavlovic; Szabolcs Muráth; Xénia Katona; Nizar B Alsharif; Paul Rouster; József Maléth; Istvan Szilagyi
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.